5 Stocks With Big Insider Buying
Hansen Medical
Another stock that insiders are jumping into here is Hansen Medical (HNSN), which develops, manufactures and markets a generation of medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies. Insiders are buying this stock into some notable weakness, since shares are down by over 30% so far in 2012.
>>4 Stocks Under $10 Showing Strength in a Weak Market
Hansen Medical has a market cap of $106.18 million and an enterprise value of $103.60. This stock trades at a premium valuation, with a price-to-sales of 5.26 and a price-to-book of 8.94. Its estimated growth rate for this year is -130%, and for next year it's pegged at 26.1%. This is barely a cash-rich company, since the total cash position on its balance sheet is $29.4 million and its total debt is $29.28 million. A beneficial owner just bought 155,155 shares, or about $283,000 worth of stock, at $1.80 to $1.89 per share. From a technical perspective, HNSN is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock has been trending sideways for the last two months, with shares moving between $2.17 on the upside and $1.64 on the downside. A move outside of that range will likely setup the next major trend for HNSN. If you're in the bull camp on HNSN, then I would look for long-biased as long as it's trending above $1.64, and then once it manages to break out above some near-term overhead resistance levels at $2 to $2.17 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 324,240 shares. If that breakout triggers soon, the HNSN will setup to re-test or possibly take out its next major overhead resistance levels at $2.40 to $2.84 a share.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV